Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jul 1;13(13):3039-49.
doi: 10.1002/j.1460-2075.1994.tb06603.x.

Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor

Affiliations

Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor

D Barettino et al. EMBO J. .

Abstract

Transcriptional activation by nuclear receptors is achieved through autonomous activation functions (AFs), a constitutive N-terminal AF-1 and a C-terminal, ligand-dependent AF-2 that comprises a motif conserved between nuclear receptors. We have performed an extensive mutational analysis of the putative AF-2 domain of chicken thyroid hormone receptor alpha (cT3R alpha). We show that the AF-2 region mediates transactivation as well as transcriptional interference (squelching), not only between the thyroid hormone and vitamin (type II) receptors, but also between type II and steroid hormone (type I) receptors. Transcriptional activation and interference require equivalent doses of the cognate ligand, and mutations in the conserved motif that reduce ligand-induced transactivation also impair transcriptional interference. When fused to the Gal4 DNA binding domain, a 35 amino acid long fragment containing the conserved motif is able to transactivate and squelch, albeit in a ligand-independent manner. Our results define the AF-2 of cT3R alpha as an autonomous transactivation domain that, in its natural context, is governed by ligand. We propose that AF-2 is probably part of a surface for interaction with either a general transcription factor or a putative bridging factor, that might be utilized by type I and II receptors.

PubMed Disclaimer

References

    1. Mol Endocrinol. 1993 Apr;7(4):616-27 - PubMed
    1. EMBO J. 1993 Jun;12(6):2349-60 - PubMed
    1. Genes Dev. 1993 Jul;7(7B):1400-10 - PubMed
    1. Nucleic Acids Res. 1993 Jun 11;21(11):2673-81 - PubMed
    1. Bioessays. 1993 May;15(5):309-15 - PubMed

Publication types